Phase 3 Trial in Subjects With Metastatic Melanoma Comparing 3 mg/kg Ipilimumab Versus 10 mg/kg Ipilimumab

PHASE3CompletedINTERVENTIONAL
Enrollment

831

Participants

Timeline

Start Date

February 17, 2012

Primary Completion Date

February 6, 2016

Study Completion Date

August 17, 2017

Conditions
Melanoma
Interventions
BIOLOGICAL

Ipilimumab

Trial Locations (88)

1011

Local Institution, Lausanne

1090

Local Institution, Vienna

1121

Fundacion Cidea, Buenos Aires

1122

Local Institution, Budapest

1200

Local Institution, Brussels

2050

Local Institution, Camperdown

2450

Local Institution, Coffs Harbour

2730

Local Institution, Herlev

3000

Local Institution, Leuven

3084

Local Institution, Heidelberg

4000

Local Institution, San Miguel de Tucumán

4020

Local Institution, Linz

4102

Local Institution, Brisbane

4215

Local Institution, Southport

5000

Local Institution, Adelaide

Local Institution, Odense

5021

Local Institution, Bergen

6530

Local Institution, George

6720

Local Institution, Szeged

7400

Local Institution, Kaposvár

7570

Local Institution, Cape Town

7700

Local Institution, Rondebosch

8000

Local Institution, Aarhus

10065

Memorial Sloan Kettering Cancer Center, New York

13385

Local Institution, Marseille

18045

St. Luke's Cancer Center - Anderson Campus, Easton

20133

Local Institution, Milan

21079

Local Institution, Dijon

21614

Local Institution, Buxtehude

24105

Local Institution, Kiel

27710

Duke University Hospital, Durham

28041

Local Institution, Madrid

28204

Levine Cancer Institute, Charlotte

30625

Local Institution, Hanover

31008

Local Institution, Navarra

31059

Local Institution, Toulouse

32207

Baptist Cancer Institute, Jacksonville

32806

Orlando Health, Inc, Orlando

33075

Local Institution, Bordeaux

35128

Local Institution, Padua

37000

Local Institution, Leon, Guanajato

38043

Local Institution, Grenoble

44093

Local Institution, Nantes

45122

Local Institution, Essen

46009

Instituto Valenciano De Oncologia, Valencia

46014

Local Institution, Valencia

47014

Local Institution, Meldola (fc)

51092

Local Institution, Reims

53100

Local Institution, Siena

55131

Local Institution, Mainz

59037

Local Institution, Lille

60068

Oncology Specialists, S.C., Park Ridge

69120

Local Institution, Heidelberg

69495

Local Institution, Pierre-Bénite

71908

Local Institution, Jerusalem

72076

Local Institution, Tübingen

75010

Local Institution, Paris

80131

Local Institution, Napoli

81675

Local Institution, Munich

90025

The Angeles Clinic And Research Institute, Los Angeles

90095

University Of California Los Angeles, Los Angeles

94805

Local Institution, Villejuif

97213

Providence Portland Medical Center, Portland

98109

Seattle Cancer Care Alliance, Seattle

T6G 1Z2

Local Institution, Edmonton

B3H 2Y9

Local Institution, Halfax

H2W1S6

Local Institution, Montreal

656 53

Local Institution, Brno

775 20

Local Institution, Olomouc

128 08

Local Institution, Prague

00144

Local Institution, Roma

1081 HV

Local Institution, Amsterdam

9713 GZ

Local Institution, Groningen

2300 RC

Local Institution, Leiden

0379

Local Institution, Oslo

80-219

Local Institution, Gdansk

60-693

Local Institution, Poznan

02-781

Local Institution, Warsaw

08036

Local Institution, Barcelona

08908

Local Institution, Barcelona

413 45

Local Institution, Gothenberg

221 85

Local Institution, Lund

171 76

Local Institution, Stockholm

901 85

Local Institution, Umeå

M20 4BX

Local Institution, Manchester

G12 OYN

Local Institution, Glasgow, Scotland

SW3 6JJ

Local Institution, London

SA2 8QA

Local Institution, Swansea

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY